USPTO serial 79370059
DISCOVERY CORE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Feb 25, 2025
- Examiner
- CASTRO, GIANCARLO
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with DISCOVERY CORE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Mathew P. Warenzak
Mathew P. Warenzak Smith, Gambrell & Russell, LLP1105 West Peachtree Street, N.E.Suite 1000Atlanta, GA 30309Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable and recorded cloudbased software for processing images, graphics and text; downloadable and recorded cloudbased software for data and document capture, transmission, storage and indexing; downloadable and recorded cloud-based database management software; computer platforms in the form of recorded or downloadable software; all the aforementioned products for use in the field of health with respect to the eyes, the brain, vascular diseases, the heart and ophthalmology; network operating software for network access servers. | ACTIVE | — |
| 042 | IT Platform as a Service (PaaS) featuring computer software platforms for research, data analysis and collaborating with medical data in ophthalmology; Software as a Service (SaaS) featuring software for research, data analysis, and collaborating with medical data in ophthalmology; database design and development; design, development, maintenance and updating of data processing software; all the aforementioned services for use in the field of health with respect to the eyes, the brain, vascular diseases, the heart and ophthalmology | ACTIVE | — |
| 044 | Remote monitoring of medical data for medical diagnosis and treatment purposes; medical information; medical information services provided via the Internet; all the aforementioned services for use in the field of health with respect to the eyes, the brain, vascular diseases, the heart and ophthalmology | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Ikerian AG
- Other trademarks owned by Ikerian AG
- Other trademarks owned by Ikerian AG
- Other trademarks in Class 009
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named DISCOVERY CORE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 15, 2025 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Sep 7, 2025 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Sep 7, 2025 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| May 25, 2025 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Feb 25, 2025 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Feb 25, 2025 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Feb 2, 2025 | ETOP | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | — |
| Nov 2, 2024 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Oct 21, 2024 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Oct 16, 2024 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Sep 24, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 24, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 4, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 21, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 20, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 20, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 20, 2024 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Jun 23, 2024 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Jun 23, 2024 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jun 23, 2024 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| May 14, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 14, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 14, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 14, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| May 14, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 14, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| May 14, 2024 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| May 14, 2024 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Apr 26, 2024 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Dec 4, 2023 | RFNP | REFUSAL PROCESSED BY IB | — |
| Nov 14, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Nov 14, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Nov 10, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Nov 9, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 31, 2023 | RFWR | NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW | — |
| Oct 25, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Oct 24, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 18, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| May 23, 2023 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| May 19, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 18, 2023 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |